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120 Epidemiology and identiﬁcation of non-lactose fermenter bacteria
in an adult cystic ﬁbrosis centre
A. Salmon1, D. Britton1, K. Schaffer1. 1St. Vincent’s University Hospital,
Microbiology, Dublin, Ireland
Introduction: St. Vincent’s University Hospital caters for approximately 300 pa-
tients in its adult CF centre. Over 70% of these patients are colonized with
P. aeruginosa. Other organisms commonly isolated are: S. aureus, S. maltophilia
and B. cepacia complex. These organisms can usually be identiﬁed by conventional
methods such as API20NE.
Some less common organisms can be more difﬁcult to identify and are less likely
to grow on media such as Maconky agar. In SVUH, we have recently begun to use
16S sequencing on difﬁcult to identify NLFs.
Method: In 2010, 24 isolates were identiﬁed by 16S sequencing.
Results: See the table.
Table 1
Organism Number
Bordetella petrii 1
Pandoraea spp. 2
Chryseobacterium spp. 7
A. xylosoxidans 7
Sphingobacterium spiritivorans 5
Delftia tsuruhatenis 1
Burkolderia gladioli 1
All isolates were sent to HPA Colindale to conﬁrm results.
Conclusion: This study has shown that organisms more commonly known as
colonizers of CF patients such as A. xylosoxidans and Pandoraea spp can prove
difﬁcult to identify by conventional means. We hope to develop a PCR assay speciﬁc
for A. xylosoxidans.
Chryseobacterium spp and Sphingobacterium spp are becoming increasingly com-
mon in our CF patients but the signiﬁcance of these organisms is still unknown.
121 Identiﬁcation of biochemically inert non-fermentative bacteria by
MALDI-TOF MS
S.Q. van Veen1,2, P.A. Dofferhoff2, E.J. Kuijper2, R.W. Brimicombe1. 1Haga
Hospital, Medical Microbiology, The Hague, Netherlands; 2LUMC, Medical
Microbiology, Leiden, Netherlands
Sputa of cystic ﬁbrosis (CF) patients often contain inert non-fermentative bacilli
rendering standard tests useless for identiﬁcation. Our reference laboratory applies
costly and time-consuming biochemical tests, fatty acid analysis and 16S sequencing
for identiﬁcation. MALDI-TOF MS can reliably identify mucoid non-inert non-
fermentative bacilli, but its performance on inert strains is unknown. We compared
MALDI-TOF MS with reference identiﬁcation tests for these bacilli. All biochem-
ical inert non-fermentative bacteria from CF sputa collected between 01–2007
and 06–2010, that were identiﬁed by the reference laboratory, were investigated
by MALD-TOF MS. Biochemical inert was deﬁned as DNAse, acetamide and
lysine test negative after 24 hours and no growth on C390/phenatroline agar. Of 78
selected isolates, 17 were unavailable for analysis and 4 were duplicates. Compared
to reference methods, 52 (91%) isolates had correct genus identiﬁcation and 5
(9%) were unidentiﬁable; none had incorrect genus identiﬁcation. Fifty isolates had
species identiﬁcation, of which 41 (82%) were correctly identiﬁed by MALDI-
TOF MS, 5 (10%) had no species identiﬁcation and 4 (8%) had incorrect species:
P. monteilli vs. P. putida (3x), A. ruhlandii vs. A. xylosoxidans. Note that P. monteilli
belongs to the P. putida group. All 11 Burkholderia sp. isolates were correctly
identiﬁed to B. cepacia complex, but within the complex 2 isolates were incorrectly
identiﬁed: B. stabilis vs. B. cenocepacia, B. multivorans vs. B. cepacia. We conclude
that MALDI-TOF MS can identify inert non-fermentative bacilli, although some
strains can only be identiﬁed to P. putida group or B. cepacia complex.
122 A one-year experience of routine identiﬁcation by MALDI-TOF MS
of non-fermenting Gram-negative rods recovered from respiratory
samples from cystic ﬁbrosis patients
A. Fernandez Olmos1, A. Rolla´n1, L. Ma´iz2, A. Lamas2, R. Canto´n1. 1Hosp.
Ramon y Cajal, Microbiology, Madrid, Spain; 2Hosp. Ramon y Cajal, CF Unit,
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Correct identiﬁcation of non-fermenting gram-negative bacteria (NFGNB) recov-
ered from respiratory samples of cystic ﬁbrosis (CF) patients by conventional
microbiology methods is often difﬁcult.
Objective: To describe our one-year experience (2010) using matrix-assisted
laser desorption ionization-time of ﬂight mass spectrometry (MT) as the routine
identiﬁcation method for NFGNB recovered from CF patients.
Methods: Data were collected by analysis of database case records of 122 adult and
paediatric patients attending at the CF Unit in 2010. A total of 80 NFGNB isolates
(excluding Pseudomonas aeruginosa and Stenotrophomonas maltophilia) were
obtained during routine follow-up visits from 44 CF patients. For the identiﬁcation,
MT examines the proﬁle of proteins detected directly from intact bacteria, using
FlexControl 3.0 and MALDI BioTyper 2.0 (Bruker Daltonik, Germany).
Results: All strains, except one (n = 79) displayed identiﬁcation using MT.
32 Achromobacter xylosoxidans, 11 Chryseobacterium indologenes, 9 Burkholderia
cepacia complex, 9 non-aeruginosa Pseudomonas, 5 Elizabethkingia meningo-
septica 3 Bordetella bronchiseptica, 2 Agrobacter tumefaciens, 2 Ochrobactrum
anthropi, 2 Pandoraea sp., 2 Sphingobacterium sp., 1 Acinetobacter sp. and
1 Alcaligenes sp. were detected. Lack of identiﬁcation (1.2%) was ascribed to
insufﬁcient database entries. MT has proven to distinguish the closely related
Burkholderia multivorans (n = 5) and B. cepacia (n = 4). Additionally, Pandoraea
pnomenusa (n = 2), not identiﬁed by phenotypical methods, were correctly identiﬁed
by MT.
Conclusions: MT is a versatile tool that improves rapid identiﬁcation of bacteria
including those recovered from CF patients with limited biochemical reactivity
frequently misidentiﬁed by the classical approach.
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SNuPE (single nucleotide primer extension)
E. Perrin1, M.C. Papaleo1, I. Maida1, M. Fondi1, R. Fani1. 1University of
Florence, Department of Evolutionary Biology ‘Leo Pardi’, Florence, Italy
Respiratory infections remain a major threat to Cystic Fibrosis (CF) patients. The
detection and correct identiﬁcation of the bacteria responsible for these infections
is critical for the therapeutic management of patients. The traditional methods of
culture and phenotypic identiﬁcation of bacteria lack both sensitivity and speciﬁcity
because many bacteria can be missed and/or misidentiﬁed. To overcome this
obstacle, a plethora of different molecular analyses have been set up in the last
years.
The aim of this study was to set up a diagnostic method based on SNuPE
(Single Nucleotide Primer Extension) for the detection of the main CF pulmonary
pathogens, which has been recently used for the discrimination of bacteria belonging
to different species. This technique allows the detection of the nucleotide located
at any site of a DNA sequence. We focused our attention on 16S rRNA gene,
which is the most commonly used marker of microbial diversity. A total of 2469
16S rDNA sequences, representative of 12 of the most common CF pathogens,
were analyzed for the presence of both highly conserved and polymorphic regions.
This analysis allowed to design a set of primers of different length for the SNuPE
technique, speciﬁc for four pathogens: Pseudomonas aeruginosa, Staphylococcus
aureus, Stenotrophomonas maltophilia and Burkholderia cepacia complex bacteria.
These primers were used either in simplex or multiplex SNuPE reactions using the
DNA of the four pathogens. Data obtained revealed that the SNuPE proﬁles allowed
the easy identiﬁcation of isolates belonging to the four species. The set up of the
system directly on CF patients sputum is in progress.
